Cite
HARVARD Citation
af Björkesten, C. et al. (2020). Objectively assessed disease activity and drug persistence during ustekinumab treatment in a nationwide real-world Crohn's disease cohort. European journal of gastroenterology & hepatology. 32 (12), p. . [Online].